Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Citius Pharmaceuticals Inc (CTXR) vs US Bancorp (USB) Price & Performance

Citius Pharmaceuticals IncTrade
US BancorpTrade

Price performance (Past 24H)

Key statistics

Citius Pharmaceuticals Inc vs US Bancorp — how do they compare? Citius Pharmaceuticals Inc trades at $0.71 (market cap $20.01M), while US Bancorp trades at $64.49 (market cap $100.17B). The key difference: US Bancorp is far larger — about 5006× Citius Pharmaceuticals Inc's market cap, and US Bancorp pays a 3.24% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

CTXRUSB
Market Cap
$20.01M$100.17B
Sector
HealthFinancials
52-Week High
$1.82$64.47
52-Week Low
$0.48$45.28
Enterprise Value
$16.23M
Dividend Yield
3.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Citius Pharmaceuticals Inc

No Aura AI signal available yet.

US Bancorp

U.S. Bancorp (USB) trades at $64.19, up 0.39% today, with a bullish technical outlook and strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $1.35 surpassing the $1.28 expectation. Revenue and net income have shown steady growth, with 2025 revenue at $28.54 billion and net income at $7.57 billion. Analyst sentiment is positive, with a consensus price target of $70.27, indicating potential upside.

The outlook for USB is favorable, supported by robust earnings growth, a solid dividend, and positive analyst ratings. Key risks include exposure to interest rate fluctuations and macroeconomic volatility, as highlighted by recent news on potential Fed rate hikes. Institutional investors have been increasing stakes, reinforcing confidence. The stock presents a compelling opportunity for value-oriented investors seeking steady returns amid a stable banking sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Read more on CTXR

About US Bancorp

As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.

Read more on USB